APP and Alzheimer disease: To analyze the effect of the chronic cerebral hypoperfusion on AD pathology, we applied BCAS to APP/PS1 mice harboring APP transgene with Swedish mutation and PSEN1dE9 transgene21,22 (Fig. 1(a)).